Adalimumab for the treatment of Crohn’s disease

Overview of attention for article published in Biologics: Targets & Therapy, September 2008

Altmetric Badge

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 114 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Highly galactosylated anti-TNF-α antibodies and uses thereof

Grant US-10174110-B2

United States of America

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

Grant US-9499615-B2

United States of America

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

Grant US-9187559-B2

United States of America

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

Grant US-9061005-B2

United States of America

Use of TNFα inhibitor for treatment of psoriasis

Grant US-8986693-B1

United States of America

Multiple-variable dose regimen for treating TNFα-related disorders

Grant US-8961974-B2

United States of America

Multiple-variable dose regimen for treating TNFα-related disorders

Grant US-8961973-B2

United States of America

Multiple-variable dose regimen for treating TNFα-related disorders

Grant US-8889136-B2

United States of America